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Table of Contents Summary: A study providing the most robust evidence to suggest 
a causal association between Slipped Capital Femoral Epiphysis and childhood obesity.  
 
What’s Known on this Subject: An association between SCFE and childhood obesity 
has long been suggested, though there have been no robust attempts to explore this 
association. The current evidence for this is almost exclusively based on small low-
quality case series from specialist centres.  
 
What this study adds: Using 600,000 children with BMI collected routinely, and 4.25 
million years of follow-up, this study provides the most robust evidence to support a 
causal association between obesity and SCFE - a strong association, a temporal 
relationship, and a marked dose-response.  
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Abstract 1 
Background.  2 
Slipped Capital Femoral Epiphysis (SCFE) is believed to be associated with Childhood 3 
Obesity, although the strength of the association is unknown. There is little evidence to 4 
suggest if this association is causal. 5 
 6 
Methods  7 
We performed a cohort study using routine data from a nationwide childhood heath 8 
screening examination at primary school entry (5-6 years old) at schools in Scotland, 9 
linked to a nationwide admissions database. A subgroup of children also had BMI 10 
recorded at exit from primary school (11–12 years old).  11 
 12 
Results 13 
BMI was available for 597,017 children at 5-6 years old school, and 39,468 at 11-12 14 
years old.  There were 4.26 million child-years at risk for SCFE. Amongst children 15 
obese at 5-6 years old, 75% remained obese at 11-12 years old. There was a very strong 16 
biological-gradient between childhood BMI at 5-6 years old and SCFE, with the risk of 17 
disease increasing by 1.7 (95% CI 1.5-1.9) for each integer increase in z-score of BMI. 18 
There risk of SCFE was almost negligible amongst children with the lowest BMI. The 19 
severely obese at 5-6 years old had 5.9 (95% CI 3.9-9.0) times greater risk of SCFE 20 
compared to those with a normal BMI, and the severely obese at 11-12 years had 17.0 21 
(95% CI 5.9-49.0) times the risk of SCFE. 22 
 23 
Conclusion 24 
High childhood BMI is very strongly associated with SCFE. The magnitude of the 25 
association, temporal relationship, dose-response, added to the plausible mechanism, 26 
offer the strongest evidence available to support a causal association. 27 
  28 
 4 
Introduction 29 
Childhood obesity is a global problem and a major cause of lifelong morbidity3. The 30 
WHO report on ending childhood obesity highlighted a lack of awareness of the 31 
consequences of childhood obesity4. Long-term outcomes of childhood obesity are 32 
well-described5-8, however there is poor understanding of short-term outcomes that may 33 
cause early childhood disability. Slipped Capital Femoral Epiphysis (SCFE) is a disease 34 
of the growth plate (physis) that causes profound lifelong disability and is believed to 35 
be caused by obesity9-14. Although an association between SCFE and childhood obesity 36 
has been suggested14, this has not yet been definitively demonstrated. Clarifying the 37 
relationship between SCFE and childhood obesity has been identified as a priority for 38 
the American Academy of Orthopedic Surgeons (AAOS)15.  39 
 40 
SCFE alters the shape of the hip resulting in bone impingement and is one of the most 41 
common reason for hip replacement surgery in adolescence and early adulthood16. It 42 
affects 1 in 1,300 individuals during childhood17, typically requires urgent surgery, and 43 
often results in deformity. Early detection and surgery can minimize the severity of 44 
deformity, although the disease frequently goes undetected for many months, often 45 
because the pain poorly localizes to the thigh or knee creating confusion for children, 46 
parents, and clinicians alike17,18. Diagnostic delays worsen clinical outcomes and can 47 
have significant medico-legal consequences for a range of clinicians18. 48 
The current evidence for an association between SCFE and childhood obesity arises 49 
from observations of increasing SCFE incidence rates coupled with rising childhood 50 
obesity10,11, and retrospective case series from specialist centres12-14,19. We sought to 51 
define the strength of this association using a nationwide population cohort study so 52 
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determine whether or not there is evidence for a causal relationship between obesity 53 
and SCFE. 54 
 55 
Methods 56 
Study Design, Setting and Population 57 
This was a historic cohort study using linked healthcare datasets within Scotland. The 58 
cohort was formed from two sources of routine universal childhood height and weight 59 
measurements at primary school entry (5-6 years old).  60 
Cohort 1 comprises the Study of Trends in Obesity in North East Scotland (STONES) 61 
collected from the Grampian region of Scotland, which represents approximately 10% 62 
of the Scottish population. Information was collected from 1970 onwards. The Scottish 63 
Community Health Index (CHI) number, which is a unique identity number amongst 64 
all Scottish residents, was collected for children born after 1992. Prior to 1992, children 65 
were matched to other datasets based upon initials, sex and date of birth. This 66 
population has been described previously20. 67 
Cohort 2 comprises the Child Health Systems Programme (CHSP-P1), which is a 68 
nationwide child health surveillance programme. CHSP-P1 began in 1995, and 69 
encompassed all of Scotland by 2003. The CHI number was collected throughout.  70 
Both cohorts were linked to the Scottish Morbidity Record (SMR01) to December 71 
2016. SMR01 is an episode-based record relating to inpatients and day cases discharged 72 
from all Scottish hospitals. SMR01 was computerised in 1968, and has been used for 73 
the financial management of hospitals since 1989. On-going data quality assessment 74 
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through periodic random sampling by NHS Scotland demonstrates high data quality 75 
with an accuracy of 89.0% (95%CI 87.9-90.1%) for the main conditions coded within 76 
SMR0121. 77 
 78 
Study Variables 79 
Height and weight of children was routinely recorded at school entry (5-6 years old) to 80 
monitor obesity trends across Scotland. Measurements were carried out by school 81 
nurses, though no information was available on measurement equipment. Other 82 
variables were sex, exact age of entry into the cohort, year of cohort entry, and after 83 
2001, an area-based quintile measure of socioeconomic status (Carstairs 2001). 84 
For a sub-group of children, their height and weight was additionally recorded at exit 85 
from primary school (aged 11-12 years old) in a linked child health surveillance 86 
programme (CHSP-P7). 87 
Outcome Measures 88 
Within SMR01 we sought an electronic diagnostic record representing SCFE (ICD-10 89 
M93.0* [Slipped upper femoral epiphysis] or ICD-9 732.2 [Unspecified slipped upper 90 
femoral epiphysis]). Cases were restricted to codes recorded at age >5 years old and 91 
<18 years old, i.e. the period ‘at risk of SCFE’.  Previous work in England using the 92 
SCFE ICD-10 code in linked-databases has demonstrated it to be specific for the 93 
identification of SCFE17. The first date of diagnostic code entry within the medical 94 
record was considered the index date. An individual could only contribute one SCFE 95 
diagnosis as laterality was not coded, so it would have been unclear whether additional 96 
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SCFE diagnosis codes truly represented a contralateral event, or a secondary admission 97 
related to the initial diagnosis (e.g. removal of metalwork). 98 
 99 
Children contributed to follow-up until they (a) reached age 18 years old, (b) received 100 
a diagnosis of SCFE or (c) were censored in December 2016 when data were extracted. 101 
 102 
Statistical Analyses 103 
BMI was calculated and expressed as a z-score of the UK 1990 reference population 104 
(UK90), adjusted for age and sex22. The transformation of BMI data to z-scores was 105 
performed using the LMS method and the zanthro package within Stata 14.123. Z-scores 106 
are a measure of how many standard deviations a score varies from the mean. There is 107 
debate around the clinical cutoff definitions for obesity in children, however to aid 108 
interpretation BMI was categorised according to cutoffs recognised by both UK90 and 109 
the Center for Disease Control and Prevention CDC24-26 (underweight<5th percentile, 110 
normal weight 5th-85th percentile, overweight ≥85th percentile, obese ≥95th percentile). 111 
We further stratified obesity as mild/moderate obesity (≥95th-99th percentile), and 112 
severe (morbid) obesity (≥99th percentile). Z-scores were converted to the clinical 113 
cutoff BMIs to improve clinical relevance and interpretation (i.e. ≥95th centile equates 114 
to a z-score ≥1.645).  115 
 116 
During data cleaning, any height or weight recorded as ‘0’ was replaced with ‘missing’. 117 
All data were explored graphically, which initially identified a decimal error in one year 118 
of source data for height/ weight, which was addressed. A height or weight outside ±5 119 
SDs were excluded as that these were likely to be spurious (height n=311, weight 120 
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n=1,159), which has been the approach previously used in the interpretation of these 121 
datasets20. 122 
  123 
The analysis was conducted using Stata 14.1 (StataCorp, College Station, TX, USA). 124 
The incidence of SCFE was calculated and stratified according to BMI at primary 125 
school entry and exit (where available). Poisson confidence intervals were calculated 126 
for rate estimations. 127 
 128 
A Cox proportional hazards regression model was fitted to estimate the SCFE hazard 129 
using the covariates age of cohort entry, sex, quintile of socioeconomic deprivation (e.g. 130 
from most affluent [first quintile] to least affluent [fifth quintile]), and z-score for BMI. 131 
The relationship between Schoenfeld residuals and event time was examined to 132 
formally test the proportional hazards assumption. Deprivation was considered within 133 
the analysis due to the known association between deprivation and obesity20. The 134 
measure of area deprivation used was the 2001 Carstairs score expressed as quintiles27, 135 
and fitted as a categorical variable. Carstairs is an area-based measure of material 136 
deprivation routinely used by the Scottish Government that includes measures of 137 
unemployment, car ownership, overcrowding, and social class. Scores are assigned to 138 
postcode sectors, with the mean population in each postcode sector being 5,012 139 
individuals. Quintile 1 represents the most affluent and quintile 5 the least. 140 
 141 
The cumulative age to SCFE diagnosis was examined by separating data into ≥85th 142 
percentile (i.e. overweight and obese children) and <85th percentile (i.e. underweight or 143 
normal). The categories were compared using log-rank tests for equality of survivor 144 
functions. 145 
 9 
 146 
The study protocol, data request application and Stata code are available as 147 
supplementary material. Reporting is in line with the REporting of studies Conducted 148 
using Observational Routinely-collected Data (RECORD) statement. Raw data is not 149 
available to be shared owing to the terms of the data sharing agreement. The threshold 150 
for statistical significance was p<0.05. 151 
 152 
Results 153 
The cohort included routine health records of 615,950 children 5-6 year old children 154 
at school entry. BMI could be calculated in 597,017 (97%) children, of whom 11.9% 155 
were overweight and 9.2% obese. The mean age of cohort entry was 66.2 months (5 156 
years and 6 months, IQR 63.0 to 72.0 months). Total follow-up amongst children for 157 
whom the BMI was known in the SCFE risk period (between 6 and 18 years old), was 158 
4.26 million years. Mean follow-up was 7-years, 1-month. 159 
 160 
A screening examination at exit from primary school (11-12 years old) was available 161 
amongst 39,468 of children from the initial cohort. BMI was available for 38,458 162 
children at both school entry and exit. BMI was broadly consistent at both time points 163 
(Table 1). Of the 3,973 children obese (≥95th percentile) at 5-6 years old, 2,963 (75%) 164 
remained obese at 11-12 years old. Amongst those that were overweight (n=5,086) at 165 
5-6 years old, 39% were obese at 11-12 years old. This was in contrast to those that 166 
were underweight (<5th percentile) at 5-6 years old (n = 973), of whom 2% were obese 167 
at 11-12 years old.  168 
 169 
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During the follow-up period 209 children received a diagnosis of SCFE. BMI was 170 
available for 195 of these children at 5-6 years, and was also available for 32 children 171 
at 11-12 years old. One case was excluded because weight was >5 standard deviations 172 
above the population mean and likely spurious. SCFE diagnoses were recorded in 117 173 
males and 92 females (5:4 male:female).  174 
 175 
Crude incidence of SCFE was 4.7 (95% CI 4.1-5.4) per 100,000 6-18 child years of 176 
risk, although the crude incidence rate is an underestimate as the cohort had an uneven 177 
distribution of follow-up. The cohort expanded in recent years, which resulted in 178 
disproportionately greater numbers of children with shorter follow-up. The age of 179 
SCFE onset is known to be non-uniform across childhood, with the peak age at 180 
diagnosis amongst 11-year-olds (incidence of 13.4 (95% CI 10.0-17.7) per 100,000 181 
child years) (Online Table 1). The incidence adjusted to the age structure of the 182 
European Standard Population was 5.45 (95% CI 4.8-6.1) per 100,000 6-18 child years 183 
of risk28.  184 
 185 
There was a strong association between BMI at 5-6 years old and SCFE. The incidence 186 
rate ratio for SCFE increased by 1.7 (95% CI 1.5-1.9; p<0.001) for each integer increase 187 
in z-score of BMI (Figure 1). Of the children who developed SCFE, 59 (30%) were 188 
obese at 5-6 years old and 25 (13%) children were overweight. The incidence rate ratio 189 
for developing SCFE compared to normal weight children at 5-6 years old was 5.9 190 
(95% CI 3.9-9.0) amongst severely obese children, 3.8 (95% CI 2.6-5.8) amongst mild 191 
or moderately obese children and 1.5 (95% CI 0.9-2.3) amongst overweight children 192 
(Table 2). Assuming that this association between SCFE and obesity was causal, the 193 
proportion of SCFE cases that would be eliminated if the BMI of the entire population 194 
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were to fit within the 5-85th BMI percentile range defining ‘normal’ (i.e. the attributable 195 
risk or excess risk, which is the difference in disease rates between an exposed 196 
population and an unexposed population) is 78% amongst obese children and 31% in 197 
overweight children. 198 
 199 
Figure 1 200 
 201 
Amongst the smaller subpopulation of children from whom BMI was available at exit 202 
from primary school (aged 11-12 years old), there were 32 children with SCFE.  The 203 
magnitude of the association at 11-12 years old was even stronger (Table 2). The 204 
incidence of SCFE in the obese 11-12 year olds was 23.8 (95% CI 14.8-36.4) per 205 
100,000 6 to 18 child years of risk, compared to 1.9 (95% CI 0.6-4.5) per 100,000 6 to 206 
18 child years amongst those of normal weight (risk ratio 12.3 (95% CI 4.6-32.6)). The 207 
risk in the severely obese was greatest, with the risk of SCFE being 17.0 (95% CI 5.9-208 
49.0) times greater in this group compared to those with normal BMI.  Of these children 209 
with SCFE, 26 (aproximately 80%) were overweight or obese compared to 35.8% in 210 
whole population of 11-12 year olds.  211 
 212 
The age of SCFE diagnosis was significantly lower amongst those overweight or obese. 213 
Overweight and obese children were diagnosed 1-year earlier than children normal or 214 
underweight (p<0.002) (Figure 2). The age of disease onset decreased by 3.3 months 215 
(95% CI 0.5-6.0, p=0.02) with each integer increase of BMI z-score.  216 
Figure 2 217 
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Carstairs score was available for 495,954 children (of whom 130 were affected by 218 
SCFE) and the incidence of SCFE was lowest in the most affluent quintile (Online 219 
Table 2). Those in the three most deprived quintiles had a similar risk of SCFE.  220 
The Cox proportional hazards model used the covariates age of cohort entry, sex, 221 
quintile of socioeconomic deprivation, and z-score for BMI. Only the z-score for BMI 222 
and deprivation score contributed significantly (Table 3). 223 
 224 
 225 
Discussion 226 
We identify a very strong association between childhood obesity and SCFE; with 227 
increasing childhood BMI both increasing the risk and reducing the age of disease-228 
onset. Obesity was recorded before any child was affected, which indicates that the 229 
association was temporal. Even children of “normal” weight are at risk of SCFE, though 230 
notably less than those overweight or obese children. Children with the lowest BMI at 231 
5-6 years old had an almost negligible lifetime risk of SCFE, those with a normal BMI 232 
had an approximate risk of 1:2500, those overweight had had an approximate risk of 233 
1:1750, those with mild and moderate obesity had a risk of 1:650, and those with severe 234 
obesity had a lifetime risk of SCFE in the order of 1:450. Although there was less data 235 
available for children at 11-12 years old, obesity at this age had the strongest association 236 
with SCFE, with the lifetime risk amongst severely obese being 17.0 (95% CI 5.9-49.0) 237 
times greater than those with a normal BMI; equating to a lifetime risk of approximately 238 
1:250. This study also supports longitudinal studies that have suggested obesity at 239 
primary school entry (kindergarten) is intimately associated with obesity later in 240 
childhood29.  241 
 242 
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Mechanical studies have demonstrated that childhood obesity may generate forces 243 
sufficient to overcome the yield point of the physis30. The peak age of SCFE is around 244 
puberty and rapid growth of the bone is believed to lower the mechanical yield point 245 
for physeal injury. It appears that obesity around puberty, rather than earlier in 246 
childhood, is the most important time-point in the development of the disease. SCFE 247 
histologically occurs through the zone of hypertrophy which is the location at which 248 
the supporting matrix of the physis is particularly redundant31. There is therefore 249 
biological plausibility through a mechanical disease mechanism for obesity causing 250 
SCFE.    251 
Prior case series from specialist centers have suggested an association between SCFE 252 
and obesity12,13,19, although these studies suffered from referral bias and poor 253 
generalizability to the wider population. Furthermore, the temporal relationship 254 
between disease and obesity has been difficult to establish; i.e. did children become 255 
obese due to hip disease or did hip disease develop due to obesity? The only prior cohort 256 
study of SCFE used a healthcare cohort from family medicine17,  which found that pre-257 
disease BMI was 1.43 (95% CI 1.20-1.68) standard deviations above the mean. 258 
However, this study did not standardize the timing of BMI measurement, was unable 259 
to determine a dose-response, had no controls, used a healthcare population, and was 260 
prone to bias because BMI was more likely to be recovered amongst unhealthy 261 
individuals. 262 
 263 
The age and sex-distribution of SCFE in this study was consistent with prior studies19,32, 264 
and incidence rates were comparable to those identified in England and Wales 265 
(incidence 4.8; 95% CI 4.4-5.2 cases per 100,000 0-16 year olds)17 and in Scotland10.  266 
 267 
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The relationship with socioeconomic deprivation has previously been proposed as a 268 
risk factor for SCFE17, although worsening deprivation and increasing childhood 269 
obesity are known to be intrinsically linked in the UK33. Even after adjusting for 270 
obesity, socioeconomic deprivation remained an independent risk factor. However, the 271 
relationship between the two is so intertwined that they may be difficult to adequately 272 
separate, particularly using area-based measures of deprivation, which may introduce 273 
an ecological fallacy.  274 
 275 
This study has many strengths compared to previous attempts to understand the 276 
association between obesity and SCFE, though there are still limitations. We were 277 
unable to quantify the effects of ethnicity as this was poorly recorded within the dataset. 278 
However, the population of Scotland in the 2011 census was 96.0% White34, and so 279 
unless ethnicity exerted an overwhelming effect, it’s availability would be unlikely to 280 
help discern small difference in disease vulnerability. No adjustment was made for co-281 
morbid disease associations, however a previous cohort identified from health records 282 
failed to find any strong evidence for an association with other childhood diseases17.  283 
We did not account for children dying or leaving Scotland, although this is unlikely to 284 
introduce bias as this is a non-directional effect related to obesity. A small number of 285 
children for whom measurements were beyond 5 standard deviations from the mean 286 
were excluded to remove spurious data, but some genuinely extreme values of BMI 287 
may have been falsely excluded. We cannot be certain regarding the exact sensitivity 288 
and specificity of the diagnostic codes used, although previous work has suggested that 289 
they are reliable17.  290 
 291 
The reduced age-of-onset in obese children is a novel finding. It is conceivable that 292 
 15 
diagnoses may be more readily made, and therefore made sooner, in obese children 293 
owing to a clinician’s heightened awareness of disease in this group. However, SCFE 294 
generally causes marked pain or a limp and is diagnosed based on clear radiographic 295 
findings. It is therefore unlikely that obese children are over-diagnosed or non-obese 296 
children are under-diagnosed. Two biological explanations are that obesity may lower 297 
the age of puberty and advance skeletal maturation, which may therefore account for 298 
the earlier SCFE age-of-onset amongst obese children35, and that a greater mechanical 299 
load may trigger earlier physeal failure in obese children. 300 
 301 
A confounding relationship is an alternative explanation for the observed effect 302 
between obesity and SCFE, i.e. a factor that is independently associated with both 303 
obesity and physeal failure. Abnormalities in serum leptin has been suggested as a 304 
possible independent risk factor for SCFE, with the suggestion that this may be a 305 
confounder36. However, the positive association between leptin and obesity more likely 306 
suggests that leptin is a disease mediator, or simply a proxy measure of ‘obesity 307 
exposure’37. 308 
 309 
We demonstrate that childhood obesity is a major risk factor for the development of 310 
SCFE. The temporal relationship, dose-response, and magnitude of the association 311 
build on the existing biological plausibility and findings of previous lower-quality 312 
studies to offer the strongest possible support to a causal relationship between 313 
childhood obesity and SCFE.  314 
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Figure 1 – A bar chart to illustrate the incidence of a diagnostic record of SCFE by 
BMI z-score at 5-6 years old. Bars represent the annual incidence rate with 95% exact 
Poisson confidence intervals. The smooth line represents disease predicted incidence 
with a Poisson regression line. 
 
Figure 2 - A cumulative age to diagnosis curve, stratified by BMI z-score at 5-6 years 
old. ≥85th percentile = overweight and obese children). <85th percentile = 
underweight or normal). 
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Table 1 - Age and sex adjusted z-score for BMI expressed in percentile cutoffs at 11-
12 years old, based on adjusted z-score BMI cut-offs at 5-6 years old.   
BMI percentile at 
11-12 years old 
UK90/ CDC 
Classification 
Number of 
children 
Percentage 
Children UNDERWEIGHT at 5-6 Years old (<5th percentile) 
 <5th percentile Underweight 302 31% 
 5th to 85th percentile Normal Weight 615 63% 
 85th to 95th 
percentile 
Overweight 
37 4% 
≥95th percentile Obese 19 2% 
Children of NORMAL weight at 5-6 Years old (5th to 85th percentile) 
 <5th percentile Underweight 843 3% 
 5th to 85th percentile Normal Weight 20,816 73% 
 85th to 95th 
percentile 
Overweight 
3,762 13% 
≥95th percentile Obese 3,005 11% 
Children OVERWEIGHT at 5-6 Years old (85th to 95th percentile) 
 <5th percentile Underweight 8 0% 
 5th to 85th percentile Normal Weight 1,772 35% 
 85th to 95th 
percentile 
Overweight 
1,329 26% 
≥95th percentile Obese 1,997 39% 
Children OBESE at 5-6 Years old (>95th percentile) 
 <5th percentile Underweight 3 0% 
 22 
 5th to 85th percentile Normal Weight 407 10% 
 85th to 95th 
percentile 
Overweight 
600 15% 
≥95th percentile Obese 2,963 75% 322 
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Table 2 - The incidence of diagnosis of SCFE, stratified by BMI at 11-12 years 323 
old per 100,000 6 to 18 child years of exposure.  324 
Age of 
measurement 
z-score for BMI 
Cases of 
SCFE 
Years at 
Risk 
Incidence of 
SCFE per 
100,000 
population 
(95% CI) 
Incidence 
Rate Ratio 
(95% CI) 
5-6 years old Underweight  
(<5th percentile) 
2 169839 1.2 (0.1–4.3) 0.4 (0.1–1.4) 
Normal 
(5th to 85th 
percentile) 
108 3212182 3.4 (2.8-4.1) 1.0 (Ref) 
Overweight 
(85th to 95th 
percentile) 
25 509586 4.9 (3.2-7.2) 1.5 (0.9–2.3) 
Obese (All) 
(≥95th percentile) 
59 381109 15.5 (11.8-20.0) 
4.6 (3.4 – 6.3) 
Mild/ Moderate 
Obesity 
 (≥95th to 99th  
percentile) 
32 244490 13.1 (9.0–18.5) 3.8 (2.6–5.8) 
Severe Obesity 
(≥99th percentile) 
27 136619 19.8 (13.0-28.8) 5.9 (3.9–9.0) 
11-12 years old Underweight  
(<5th percentile) 
1 12855 7.8 (0-43.3) 4.0 (0.5-34.4) 
Normal 
(5th to 85th 
percentile) 
5 258453 1.9 (0.6-4.5) 1.0 (Ref) 
Overweight 5 62791 7.9 (2.6-18.5) 4.1 (1.2-14.2) 
 24 
(85th to 95th 
percentile) 
Obese (All) 
(≥95th percentile) 
21 88159 23.8 (14.8-36.4) 
12.3 (4.5 – 
41.8) 
Mild/ Moderate 
Obesity 
 (≥95th to 99th  
percentile) 
10 54757 18.3 (8.8–33.6) 9.4 (3.2-27.6) 
 Severe Obesity 
(≥99th percentile) 
11 33402 32.9 (16.3-58.5) 17.0 (5.9-49.0) 
 325 
 326 
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Table 3 – Cox proportional hazards regression model demonstrating predictors 328 
of SCFE. The co-variables used in the final model were BMI z-score and 329 
quintiles of socioeconomic deprivation as other co-variables (cohort entry and 330 
sex) did not contribute to the model. 331 
 332 
Descriptor Odds Ratio (95% 
CI) 
P-value 
Z-score for BMI at 5-6 years old (per 
integer increase) 
1.75 (1.51-2.02) <0.001 
Deprivation    
 1 - Most Affluent 1 (ref)  
 2 1.75 (0.85- 3.63) 0.13 
 3 2.59 (1.31- 5.09) 0.006 
 4 2.24 (1.13- 4.44) 0.021 
 5 - Least Affluent 2.50 (1.23- 5.07) 0.012 
 333 
 334 
 335 
 336 
